PHOTO
The profit increase was ascribed to performance improvement and higher sales from the pharma and explosives sectors, the company said in a bourse disclosure on Sunday.
Moreover, the decrease in expected credit loss provision and finance cost also contributed to the profit growth.
Sales grew to SAR 3.306 billion last year, compared to SAR 2.949 billion in 2019.
During the first nine months of 2020, the company reported net profits of SAR 96.99 million, up from SAR 83.6 million in the corresponding period a year earlier.
All Rights Reserved - Mubasher Info © 2005 - 2021 Provided by SyndiGate Media Inc. (Syndigate.info).